Prostate cancer: does radiation therapy raise the risk for second cancers?

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

 

  • Radiation therapy (RT) was not associated with overall increased risk for second cancer (SC).
  • SC risk was increased with RT-only, but not with RT after radical prostatectomy (RP+RT).

 

Why this matters

  • Previous reports have provided conflicting results.

Key results

  • 10-y SC incidence was 15.9%, 13.2%, and 10.5% for RT-only, RP+RT, and RP-only (P<.0001). 
  • Incidence of colon cancer was 1.7%, 2.0%, and 1.1%, respectively. 
  • Rectal cancer occurred in 1.1%, 0.3%, and 0.6%. 
  • Bladder cancer occurred in 2.7%, 1.5%, and 1.1%. 
  • Nonmelanoma skin cancer (NMSC) occurred in 2.1%, 1.6%, and 1.2%. 
  • Incidence of lung cancer was 2.2% with RT-only and 1.2% with RP regardless of postoperative RT.
  • Age, T- and N-category and treatment were predictors for SC development. 
  • RP+RT and RT-only patients were at higher risk for colon cancer (HR, 1.903 and 1.326; P=.0035). 
  • Risk for rectal cancer increased with RT-only (HR, 1.751; P=.0077), and decreased with RP+RT (HR, 0.638; P=.0077). 
  • RT-only patients were at high risk for lung cancer (HR, 1.733; P=.0011). 
  • RT-only and RP+RT were associated with increased risk for bladder cancer (HR, 2.098 and 1.601; P<.001) and NMSC (HR, 1.658 and 1.305; P<.0020).

Study design

  • Retrospective study (N=19,538).
  • Funding: None.

Limitations

  • Small number of events in some subgroups.